(Q36926619)

English

Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance

scientific article published on 03 February 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance (English)

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

1 reference

based on heuristic

inferred from title

pneumococcal conjugate vaccine

1 reference

based on heuristic

inferred from title

4

object named as

Ruth Lynfield

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

William Schaffner

3

object named as

William Schaffner

1 reference

Europe PubMed Central

17 August 2017

PMC publication ID

Shelley M Zansky

8

object named as

Shelley M Zansky

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Cynthia G Whitney

22

object named as

Cynthia G Whitney

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

15

object named as

Elizabeth R Zell

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Monica M Farley

14

object named as

Monica M Farley

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Nancy M Bennett

6

object named as

Nancy M Bennett

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

9

object named as

Lee H Harrison

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

7

object named as

Susan Petit

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Arthur Reingold

10

object named as

Arthur Reingold

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

17

object named as

Tracy Pondo

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Ruth Link-Gelles

2

object named as

Ruth Link-Gelles

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Catherine A Lexau

5

object named as

Catherine Lexau

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

20

object named as

Bernard Beall

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Karen Scherzinger

12

object named as

Karen Scherzinger

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

19

object named as

Lesley McGee

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

author name string

Matthew R Moore

1

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Lisa Miller

11

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Ann Thomas

13

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Thomas H Taylor

16

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Loren Rodgers

18

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

James H Jorgensen

21

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

publication date

3 February 2015

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Lancet Infectious Diseases

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

15

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

301-309

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4876855

29 September 2017

Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4876855

29 September 2017

U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4876855

29 September 2017

Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children - Advisory Committee on Immunization Practices (ACIP), 2010

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4876855

29 September 2017

Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4876855

27 June 2018

Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4876855

27 June 2018

Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4876855

27 June 2018

Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4876855

27 June 2018

Differential effects of pneumococcal vaccines against serotypes 6A and 6C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4876855

27 June 2018

Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among children aged 6-18 years with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4876855

4 September 2018

National, state, and local area vaccination coverage among children aged 19-35 months--United States, 2011.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4876855

4 September 2018

Invasive pneumococcal disease and 13-valent pneumococcal conjugate vaccine (PCV13) coverage among children aged ≤59 months---selected U.S. regions, 2010--2011.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4876855

4 September 2018

Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4876855

4 September 2018

Healthcare utilization and cost of pneumococcal disease in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4876855

4 September 2018

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4876855

4 September 2018

National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4876855

4 September 2018

Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4876855

4 September 2018

Effect of 13-valent pneumococcal conjugate vaccine on admissions to hospital 2 years after its introduction in the USA: a time series analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4876855

20 October 2018

Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis media.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2971081-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2971081-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of antibiotic-nonsusceptible Streptococcus pneumoniae with conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2971081-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of conjugate 7-valent vaccination in Belgium: addressing methodological challenges

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2971081-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP)

1 reference

https://pubmed.ncbi.nlm.nih.gov/25656600

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP)

1 reference

https://pubmed.ncbi.nlm.nih.gov/25656600

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/S1473-3099(14)71081-3

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36926619&oldid=1743291758"